CLDN3 and necrotizing enterocolitis: We investigated the value of fecal biomarker as well as some non-specific laboratory metrics in the progression of NEC from Stage II to Stage III and found that fecal HBD-2 and Claudin-3 may be potential biomarkers in the prediction of deterioration of NEC.